166 related articles for article (PubMed ID: 17451196)
1. Selective COX-2 inhibitor, NS-398, suppresses cellular proliferation in human hepatocellular carcinoma cell lines via cell cycle arrest.
Baek JY; Hur W; Wang JS; Bae SH; Yoon SK
World J Gastroenterol; 2007 Feb; 13(8):1175-81. PubMed ID: 17451196
[TBL] [Abstract][Full Text] [Related]
2. NS-398, a selective cyclooxygenase 2 inhibitor, inhibited cell growth and induced cell cycle arrest in human hepatocellular carcinoma cell lines.
Cheng J; Imanishi H; Amuro Y; Hada T
Int J Cancer; 2002 Jun; 99(5):755-61. PubMed ID: 12115513
[TBL] [Abstract][Full Text] [Related]
3. Cyclooxygenase-2 inhibitor and interferon-beta synergistically induce apoptosis in human hepatoma cells in vitro and in vivo.
Nakamoto N; Higuchi H; Kanamori H; Kurita S; Tada S; Takaishi H; Toda K; Yamada T; Kumagai N; Saito H; Hibi T
Int J Oncol; 2006 Sep; 29(3):625-35. PubMed ID: 16865278
[TBL] [Abstract][Full Text] [Related]
4. Specific COX-2 inhibitor, meloxicam, suppresses proliferation and induces apoptosis in human HepG2 hepatocellular carcinoma cells.
Li J; Chen X; Dong X; Xu Z; Jiang H; Sun X
J Gastroenterol Hepatol; 2006 Dec; 21(12):1814-20. PubMed ID: 17074019
[TBL] [Abstract][Full Text] [Related]
5. Specific COX-2 inhibitor, NS-398, suppresses cellular proliferation and induces apoptosis in human hepatocellular carcinoma cells.
Cheng AS; Chan HL; Leung WK; Wong N; Johnson PJ; Sung JJ
Int J Oncol; 2003 Jul; 23(1):113-9. PubMed ID: 12792783
[TBL] [Abstract][Full Text] [Related]
6. Inhibited proliferation of cyclooxygenase-2 expressing human hepatoma cells by NS-398, a selective COX-2 inhibitor.
Hu KQ; Yu CH; Mineyama Y; McCracken JD; Hillebrand DJ; Hasan M
Int J Oncol; 2003 Apr; 22(4):757-63. PubMed ID: 12632065
[TBL] [Abstract][Full Text] [Related]
7. Expression of cyclooxygenase-2 (COX-2) in hepatocellular carcinoma and growth inhibition of hepatoma cell lines by a COX-2 inhibitor, NS-398.
Bae SH; Jung ES; Park YM; Kim BS; Kim BK; Kim DG; Ryu WS
Clin Cancer Res; 2001 May; 7(5):1410-8. PubMed ID: 11350912
[TBL] [Abstract][Full Text] [Related]
8. Specific COX-2 inhibitor NS398 induces apoptosis in human liver cancer cell line HepG2 through BCL-2.
Huang DS; Shen KZ; Wei JF; Liang TB; Zheng SS; Xie HY
World J Gastroenterol; 2005 Jan; 11(2):204-7. PubMed ID: 15633216
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of growth inhibitory effects of cyclooxygenase-2 inhibitor-NS398 on cancer cells.
Li S; Tong Q; Zhang W; Wang Q; Chen Z; Wu Q
Cancer Invest; 2008 May; 26(4):333-7. PubMed ID: 18443952
[TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenase-2 (COX-2) is directly involved but not decisive in proliferation of human hepatocellular carcinoma cells.
Park JW; Park JE; Lee JA; Lee CW; Kim CM
J Cancer Res Clin Oncol; 2006 Mar; 132(3):184-92. PubMed ID: 16331492
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of cyclooxygenase-2 in human HepG2, Bel-7402 and SMMC-7721 hepatoma cell lines and mechanism of cyclooxygenase-2 selective inhibitor celecoxib-induced cell growth inhibition and apoptosis.
Liu NB; Peng T; Pan C; Yao YY; Shen B; Leng J
World J Gastroenterol; 2005 Oct; 11(40):6281-7. PubMed ID: 16419156
[TBL] [Abstract][Full Text] [Related]
12. [Down-regulation of survivin in growth inhibition of hepatoma cells induced by a selective cyclooxygenase-2 inhibitor].
Song IH; Kim DW; Shin KC; Shin HD; Yun SY; Kim SB; Shin JE; Kim HJ; Kim EY
Korean J Hepatol; 2008 Sep; 14(3):351-9. PubMed ID: 18815458
[TBL] [Abstract][Full Text] [Related]
13. Parthenolide cooperates with NS398 to inhibit growth of human hepatocellular carcinoma cells through effects on apoptosis and G0-G1 cell cycle arrest.
Ralstin MC; Gage EA; Yip-Schneider MT; Klein PJ; Wiebke EA; Schmidt CM
Mol Cancer Res; 2006 Jun; 4(6):387-99. PubMed ID: 16778086
[TBL] [Abstract][Full Text] [Related]
14. [Effects of selective cyclooxygenase-2 inhibitor NS-398 on proliferation and cell cycle progression of hepatocarcinoma cells].
Zhang LY; Wang X; Zhang YC; Fu SJ; Ma L
Zhonghua Gan Zang Bing Za Zhi; 2005 Jul; 13(7):547-8. PubMed ID: 16042901
[No Abstract] [Full Text] [Related]
15. Mechanisms of anti-proliferative effect of JTE-522, a selective cyclooxygenase-2 inhibitor, on human liver cancer cells.
Nagahara T; Okano J; Murawaki Y
Oncol Rep; 2007 Nov; 18(5):1281-90. PubMed ID: 17914586
[TBL] [Abstract][Full Text] [Related]
16. Potent cell growth inhibitory effects in hepatitis B virus X protein positive hepatocellular carcinoma cells by the selective cyclooxygenase-2 inhibitor celecoxib.
Xie H; Gao L; Chai N; Song J; Wang J; Song Z; Chen C; Pan Y; Zhao L; Sun S; Wu K; Feitelson MA; Liu J; Fan D
Mol Carcinog; 2009 Jan; 48(1):56-65. PubMed ID: 18506760
[TBL] [Abstract][Full Text] [Related]
17. Proteomics reveals protein profile changes in cyclooxygenase-2 inhibitor-treated endometrial cancer cells.
Yi Z; Jingting C; Yu Z
Int J Gynecol Cancer; 2009 Apr; 19(3):326-33. PubMed ID: 19407554
[TBL] [Abstract][Full Text] [Related]
18. Dual action of a selective cyclooxygenase-2 inhibitor on vascular endothelial growth factor expression in human hepatocellular carcinoma cells: novel involvement of discoidin domain receptor 2.
Lee NO; Park JW; Lee JA; Shim JH; Kong SY; Kim KT; Lee YS
J Cancer Res Clin Oncol; 2012 Jan; 138(1):73-84. PubMed ID: 22009181
[TBL] [Abstract][Full Text] [Related]
19. Combination of cyclooxygenase-2 inhibitor and doxorubicin increases the growth inhibition and apoptosis in human hepatocellular carcinoma cells.
Pan YY; Xu SP; Jia XY; Xu HQ; Zhang Y; Rui LX; Wei W
Exp Oncol; 2007 Mar; 29(1):23-9. PubMed ID: 17431384
[TBL] [Abstract][Full Text] [Related]
20. Selective cyclooxygenase-2 inhibitors inhibit growth and induce apoptosis of bladder cancer.
Gee J; Lee IL; Jendiroba D; Fischer SM; Grossman HB; Sabichi AL
Oncol Rep; 2006 Feb; 15(2):471-7. PubMed ID: 16391871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
